| HOME >> MEDICINE >> TECHNOLOGY |
Inverness Medical Innovations, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in $000s)
September 30, December 31,
2009 2008
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $555,871 $141,324
Restricted cash 3,098 2,748
Marketable securities 907 1,763
Accounts receivable, net 363,054 280,608
Inventories, net 223,103 199,131
Prepaid expenses and other current assets 169,370 196,969
Total current assets 1,315,403 822,543
PROPERTY, PLANT AND EQUIPMENT, NET 324,020 284,483
GOODWILL AND OTHER INTANGIBLE ASSETS, NET 5,188,346 4,717,704
DEFERRED FINANCING COSTS AND OTHER ASSETS, NET 154,332 130,630
Total assets $6,982,101 $5,955,360
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Current portion of notes payable $19,612 $19,509
Other current liabilities 450,311 345,836
Total current liabilities 469,923 365,345
LONG-TERM LIABILITIES:
Notes payable, net of current portion 2,134,398 1,501,025
Deferred tax liabilities 506,074 46
'/>"/>
| SOURCE Inverness Medical Innovations, Inc. Copyright©2009 PR Newswire. All rights reserved |